BioSpace News Archive

Drug Development

Xcovery Announces First Cohort of Patients Dosed in a Phase 1/2 Clinical Trial of Vorolanib in Combination with Nivolumab for Treatment of Non-Small Cell Lung Cancer or Thymic Carcinoma

This investigator-initiated trial is led by Dr. Leora Horn of the Vanderbilt-Ingram Cancer Center.

August 1, 2018
·
2 min read
Business

ANI Pharmaceuticals Schedules Conference Call to Discuss Second Quarter and Year-to-Date 2018 Financial Results

ANI Pharmaceuticals, Inc. announced today that the Company plans to release its second quarter and year-to-date 2018 financial results on Tuesday, August 7, 2018, before the opening of the U.S. financial markets.

August 1, 2018
·
1 min read
Deals

Croda Invests in SiSaf’s Novel Bio-Courier Technology

Croda has also acquired a minority shareholding in SiSaf.

August 1, 2018
·
3 min read
Business

GC Pharma Reports Q2 2018 Results

Q2 Performance was In-line with Expectations

August 1, 2018
·
1 min read
Deals

ReViral Announces US$55 Million Series B Fundraising to Advance RSV Clinical Studies

ReViral announced the successful completion of a US$55 million Series B financing.

August 1, 2018
·
5 min read
Deals

PENTAX Medical acquires majority stake in PlasmaBiotics SAS, a technology innovator focused on the ultra-fast channel drying and active storage of endoscopes

PENTAX Medical announced that it has acquired a controlling interest in PlasmaBiotics SAS, based in Paris, France, a company that designs, manufactures and markets devices for drying and storage of endoscopes.

August 1, 2018
·
3 min read
QIAGEN’s careHPV™ Test Wins WHO Prequalification Status for Cervical Cancer Screening

WHO Prequalification recognizes the important role that the careHPV Test can have in screening women in emerging countries for HPV

August 1, 2018
·
1 min read
Business

QIAGEN Creates Collaboration with Japan’s Largest Clinical Laboratory Testing Company, SRL, to Accelerate Launch of Companion Diagnostics

Day-one lab readiness speeds commercialization and reimbursement in personalized medicine

August 1, 2018
·
1 min read
Business

Dr Ignacio Faus appointed as new CEO of MOLOGEN AG

The Supervisory Board of biopharmaceutical Company MOLOGEN AG appointed Dr Ignacio Faus as Member of the Executive Board and new Chief Executive Officer (CEO) of MOLOGEN AG with effect from August 1, 2018.

August 1, 2018
·
5 min read
Biotech Bay

Nurx Launches In Wisconsin, Offering Home Delivery Of Affordable Birth Control And HIV Prevention

Telemedicine Platform Expands Access to Prescription Birth Control and PrEP for HIV Prevention To Combat Wisconsin’s Unintended Pregnancy Rate and Increasing New HIV Cases

August 1, 2018
·
4 min read